Keybanc analyst Kenneth Zener downgrades Sherwin-Williams (NYSE:SHW) from Overweight to Sector Weight.
Gilead Sciences Sees FY23 Sales $26B-$26.5B; EPS $4.75-$5.15 Vs $5.3-$5.70 Prior Est
Guidance and Outlook
For the full-year, Gilead expects:
Total product sales between $26.0 billion and $26.5 billion, unchanged from prior guidance.
Total product sales, excluding